UPMC researchers solving treatment resistance in most common breast cancer


(University of Pittsburgh Schools of the Health Sciences) For the first time researchers have identified recurrent ESR1 fusion proteins in human breast cancer, to understand how they function and help lead to improved treatments for the disease.